APIMEDS PHARMACEUTICALS US, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -2,440.3% | -2,440.3% | -184.3% |
| FY2024 | 102.3% | 102.3% | -10,645.6% |
| FY2025 | -3.9% | -3.9% | -3.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -2,440.3% | -2,440.3% | -184.3% |
| FY2024 | 102.3% | 102.3% | -10,645.6% |
| FY2025 | -3.9% | -3.9% | -3.7% |